Correlation Between Novartis and Grifols SA
Can any of the company-specific risk be diversified away by investing in both Novartis and Grifols SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Grifols SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Grifols SA ADR, you can compare the effects of market volatilities on Novartis and Grifols SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Grifols SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Grifols SA.
Diversification Opportunities for Novartis and Grifols SA
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Novartis and Grifols is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Grifols SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grifols SA ADR and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Grifols SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grifols SA ADR has no effect on the direction of Novartis i.e., Novartis and Grifols SA go up and down completely randomly.
Pair Corralation between Novartis and Grifols SA
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.27 times more return on investment than Grifols SA. However, Novartis AG ADR is 3.71 times less risky than Grifols SA. It trades about -0.07 of its potential returns per unit of risk. Grifols SA ADR is currently generating about -0.11 per unit of risk. If you would invest 9,845 in Novartis AG ADR on October 23, 2024 and sell it today you would lose (92.00) from holding Novartis AG ADR or give up 0.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novartis AG ADR vs. Grifols SA ADR
Performance |
| Timeline |
| Novartis AG ADR |
| Grifols SA ADR |
Novartis and Grifols SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and Grifols SA
The main advantage of trading using opposite Novartis and Grifols SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Grifols SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grifols SA will offset losses from the drop in Grifols SA's long position.| Novartis vs. DiaMedica Therapeutics | Novartis vs. Seres Therapeutics | Novartis vs. Inhibikase Therapeutics | Novartis vs. Oncolytics Biotech |
| Grifols SA vs. Novartis AG ADR | Grifols SA vs. AstraZeneca PLC ADR | Grifols SA vs. GlaxoSmithKline PLC ADR | Grifols SA vs. Roche Holding Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |